aTyr Pharma (ATYR) PT Lowered to $1 at RBC Capital
Tweet
Share
E-mailGet Alerts ATYR Hot Sheet
Price: $0.52 -7.14%
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on aTyr Pharma (NASDAQ: ATYR) to $1.00 (from $1.50) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
